This inventor holds 1 USPTO granted patent. Top assignee: Axceso Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sojin Park: Innovator in Cancer Treatment
Introduction
Sojin Park is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. Her innovative work has led to the development of a unique compound that holds promise for therapeutic applications.
Latest Patents
Sojin Park holds a patent for a pyrimido pyrimidinone compound and a pharmaceutical composition comprising the same. This patent describes a compound that effectively inhibits PD-L1 expression, which is crucial in cancer progression. The pharmaceutical composition containing this compound can be utilized for the treatment or prevention of cancer, showcasing its potential impact on healthcare.
Career Highlights
Sojin Park is associated with Axceso Biopharma Co., Ltd., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Collaborations
Sojin Park collaborates with notable colleagues, including Young Jun Park and Sung Jun Park. These partnerships enhance her research capabilities and contribute to the development of effective pharmaceutical solutions.
Conclusion
Sojin Park's contributions to cancer treatment through her innovative patent highlight her role as a leading inventor in the pharmaceutical industry. Her work exemplifies the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile